New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 7, 2023 - The FDA approved a new oral pellet formulation of Pfizer’s Xalkori (crizotinib).
Download PDF
Return to publications
